[EN] METHODS OF USE FOR OPSIN BINDING LIGANDS<br/>[FR] PROCÉDÉS D'UTILISATION DE LIGANDS DE LIAISON DE L'OPSINE
申请人:BIKAM PHARMACEUTICALS INC
公开号:WO2010074746A1
公开(公告)日:2010-07-01
Methods of use of compounds of the Formula I1 II, III, IV and/or V are disclosed for treating ophthalmic conditions related to the production of toxic visual cycle products that accumulate in the eye, and are associated with reactions of the visual cycle during medical procedures that expose the eye to light, most commonly the various forms of ophthalmic surgery and stabilize the proper folding of mutant opsins. Compounds and compositions useful in the these methods, either alone or in combination with other therapeutic agents, are also described, along with methods of screening for new agents useful in said treatments.
公开了利用公式I1 II、III、IV和/或V的化合物治疗与在眼睛中积聚的有毒视觉循环产物有关的眼科疾病的方法,这些产物与暴露于光线的医疗程序期间的视觉循环反应有关,最常见的是各种形式的眼科手术,并稳定突变视蛋白的正确折叠。还描述了在这些方法中有用的化合物和组合物,无论是单独使用还是与其他治疗剂结合使用,以及筛选用于上述治疗的新药物的方法。